Scientists uncover how low-dose metformin targets brain pathways to lower blood sugar, opening fresh avenues for safer and smarter diabetes therapies.
Study: Low-dose metformin requires brain Rap1 for its antidiabetic action. Image…
Metformin’s blood sugar control starts in the brain, not just the liver, study finds
